Glasgow biotech firm gets £2.4 million funding for growth

Scottish biotechnology business Fixed Phage has secured additional investment to scale up its work tackling new microbial threats that pose risks to human health and agricultural production.

A latest funding round has seen current and new investors, including Scottish Enterprise, pledge a further £2.4m to support its growth plans.

Read more HERE.